Allergan plc Story

AGN -- USA Stock  

USD 158.25  1.91  1.22%

Macroaxis News
  
By Vlad Skutelnik
This piece will outline Allergan plc. I will inspect the possibilities of making Allergan plc into a steady grower in March inspite the current mess. Allthough quite persistent forward indicators, Allergan plc is not utilizing all of its potentials. The existing stock price mess, may contribute to short standing losses for the partners. We found thirty-seven available fundamental indicators for Allergan plc which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Allergan plc fundamentals including its Number of Shares Shorted, Cash and Equivalents, Earnings Per Share, as well as the relationship between Revenue and Current Ratio . Given that Allergan plc has Price to Earning of 24.00X, we suggest you validate Allergan plc prevailing market performance to make sure the company can sustain itself down the road. Use Allergan plc to enhance returns of your portfolios. The stock experiences large bullish trend. Check odds of Allergan plc to be traded at $154.43 in 30 days.
Does Allergan plc have anything left?

Allergan plc has 23.8B in debt with debt to equity (D/E) ratio of 36.5 . This implies that the stock may be unable to create cash to meet all of its financial commitments. The entity has Current Ratio of 1.3 demonstrating that it is in a questionable position to pay out its financial commitments when the payables are due. The company dividends can provide a clue to current valuation of the stock. This firm one year expected dividend income is about $1.42 per share. The company has Net Profit Margin of (32.28) % which means that it does not effectively controls expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 44.99 % which entails that for every 100 dollars of revenue it generated 0.45 of operating income.


The firm has beta of 1.37. As market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Allergan plc will likely underperform. The small decline in market price for the last few months could raise concerns from investors as the firm closed today at a share price of 138.21 on 2622291 in volume. The company directors and management did not add much value to Allergan plc investors in January. However, diversifying your holdings with Allergan plc or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 2.5331. The current volatility is consistent with the ongoing market swings in January 2019 as well as with Allergan plc unsystematic, company specific events. Allergan plc preserves 44.55b of market capitalization. Allergan plc is selling at 140.39. That is 1.15 percent increase. Day high is 141.23. Allergan plc Liabilities Non Current is increasing over the last 5 years. The previous year value of Allergan plc Liabilities Non Current was 32,405,561,053. Allergan plc Net Cash Flow from Financing is decreasing over the last 5 years. Furthermore, Allergan plc Property Plant and Equipment Net is decreasing over the last 5 years. The previous year value of Allergan plc Property Plant and Equipment Net was 1,312,956,842.

 2013 2014 2015 2016 2018 (projected)
Allergan plc Current Assets 4,434,700,000  7,110,600,000  8,579,100,000  17,857,900,000  16,072,110,000 
Allergan plc Total Assets 22,725,900,000  52,758,000,000  135,583,300,000  128,986,300,000  116,087,670,000 

To conclude, we believe that at this point Allergan plc is undervalued with below average odds of financial distress within the next 2 years. Our ongoing buy or sell advice on the corporation is Cautious Hold.

Allergan plc Revenue

Exercise or conversion by Boyer Andrew S of 9000 shares of Allergan plc subject to Rule 16b-3

Allergan plc insider trading alert for exercise of common stock par value $0.0033 by Boyer Andrew S, VP Sales Marketing, on August 18, 2019. This event was filed by Allergan Plc with SEC on 2005-08-24. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

About Contributor

Vlad Skutelnik
   Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management. View Profile
This story should be regarded as informational only and should not be considered as solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of Allergan plc. Please refer to our Terms of Use for any information regarding our disclosure principles.

Story Momentum

This article from Macroaxis published on 13 of February contributed to the next trading period price depreciation.The overall trading delta to the next next day price was 1.18% . The overall trading delta when the story was published to current price is 11.90% .

Similar stores for Allergan plc

a day ago at MacroaxisInsider 
Exercise or conversion by Boyer Andrew S of 9000 shares of Allergan plc subject to Rule 16b-3
Macroaxis News
Filed transaction by Allergan Plc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
few days ago at nysenewsguru.com 
Scrutiny of these stocks Allergan plc, - NyseNewsGuru
news
Scrutiny of these stocks Allergan plc, NyseNewsGuruOn Tuesday, The Allergan plc, belongs to the sector of Healthcare of the USA. Each buying and selling session display one-of-a-kind actions and ...
over a week ago at MacroaxisInsider 
Acquisition by Heimers Edward F Jr of 5000 shares of Allergan plc subject to Rule 16b-3
Macroaxis News
Filed transaction by Allergan Plc officer. Grant, award or other acquisition pursuant to Rule 16b-3
over a week ago at MacroaxisInsider 
Payment of 2751 shares by Buchen David A of Allergan plc subject to Rule 16b-3
Macroaxis News
Filed transaction by Allergan Plc officer. Payment of exercise price or tax liability by delivering or withholding securities
over two weeks ago at newssimatic.us 
Notable Volatile Movements Allergan Plc, - NewsSimatic
news
Notable Volatile Movements Allergan Plc, NewsSimaticCurrent Trend Allergan plc, StockNewsWorldA Compelling Investment With One Caveat Allergan plc BOV NewsIts been a crucial week for Allergan plc heres what analysts have to say. The MAK DailyPure Financial Advisors Inc. Has 361000 Stake in Allergan plc Mayfield RecorderView full coverage on Google News
over two weeks ago at MacroaxisInsider 
Allergan plc exotic insider transaction detected
Macroaxis News
Filed transaction by Allergan Plc director. Unconventional Insider trading
over three weeks ago at mayfieldrecorder.com 
Cacti Asset Management LLC Acquires 2,009 Shares of Allergan plc - Mayfield Recorder
news
Cacti Asset Management LLC Acquires 2,009 Shares of Allergan plc Mayfield RecorderCacti Asset Management LLC raised its holdings in shares of Allergan plc by 0.9 percent in the second quarter, HoldingsChannel.com reports. The firm ...
over a month ago at mayfieldrecorder.com 
Marshall Wace North America L.P. Buys New Shares in Allergan plc - Mayfield Recorder
news
Marshall Wace North America L.P. Buys New Shares in Allergan plc Mayfield RecorderMarshall Wace North America L.P. purchased a new position in shares of Allergan plc during the 1st quarter, according to its most recent 13F filing ...
over a month ago at MacroaxisInsider 
Payment of 491 shares by Bailey A Robert D of Allergan plc subject to Rule 16b-3
Macroaxis News
Filed transaction by Allergan Plc officer. Payment of exercise price or tax liability by delivering or withholding securities
over a month ago at MacroaxisInsider 
Disposition of 73812 shares by Joyce R Todd of Allergan plc subject to Rule 16b-3
Macroaxis News
Filed transaction by Allergan Plc officer. Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3
over a month ago at newssmooth.com 
Data Shows Recession Fears May Be Overblown Allergan plc, - NewsSmooth
news
Data Shows Recession Fears May Be Overblown Allergan plc, NewsSmoothClearbridge Investments LLC Has 1.34 Billion Stock Holdings in Allergan plc Tech Know BitsEPS for Allergan plc Expected At 4.28 Profile of 4 Analysts Covering CF Industries Holdings, Inc. Stocks BeatBrokerages Set Allergan plc PT at 173.61 Rockland RegisterMorningstar Investment Services LLC Boosts Stock Position in Allergan plc Mayfield RecorderView full coverage on Google News
over three months ago at www.fidaily.com 
Allergan plc Holdings Raised by FTB Advisors Inc. - Finance Daily
news
Allergan plc Holdings Raised by FTB Advisors Inc. Finance Daily3.54 EPS Expected for Allergan plc Invest TribuneZeroing in on Company Shares of Allergan plc Hermann HeraldAllergan plc Analysts See 3.54 EPS The MAK DailyView full coverage on Google News
over six months ago at kymanews.com 
Are Analysts Chasing Allergan plc Like the Rest of Us - KYMA News
news
Are Analysts Chasing Allergan plc Like the Rest of Us KYMA NewsA handful of technical analysis tools are suggesting that Allergan plc overall gets 56. percent Sell rating. The stock is also flashing a Sell from the ...

Compare Allergan plc

Compare Allergan plc To Peers

Price to Earnings To Growth

Price to Earnings To Growth Comparative Analysis

  Price to Earnings To Growth 
      Allergan plc Comparables 
Allergan plc is currently under evaluation in price to earnings to growth category among related companies. PEG Ratio indicates potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate.Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates future growth of a firm. The low PEG ratio usually implies that equity instrument is undervalued; where as PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Check also Allergan plc Hype Analysis, Allergan plc Correlation and Allergan plc Performance. Please also try Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Search macroaxis.com